Breaking News
Investing Pro 0
Free Webinar - Webinar: Simplify Options Trading | Thursday, September 28, 2023 | 08:00PM EDT Enroll Now
Close

Catalent Inc (0C8)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
42.9500 +0.2000    +0.47%
02:00:00 - Delayed Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US1488061029 
S/N:  A112H2
  • Volume: 0
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 42.9500 - 42.9500
Catalent Inc 42.9500 +0.2000 +0.47%

NYSE:0C8 Financials

 
A brief overview of the NYSE:CTLT financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Catalent Inc over time.

Catalent, Inc. reported earnings results for the fourth quarter and full year ended June 30, 2023. For the fourth quarter, the company reported sales was USD 1,068 million compared to USD 1,287 million a year ago. Net loss was USD 86 million compared to net income of USD 168 million a year ago. Basic loss per share from continuing operations was USD 0.48 compared to basic earnings per share from continuing operations of USD 0.94 a year ago. Diluted loss per share from continuing operations was USD 0.48 compared to diluted earnings per share from continuing operations of USD 0.93 a year ago.For the full year, sales was USD 4,276 million compared to USD 4,802 million a year ago. Net loss was USD 232 million compared to net income of USD 499 million a year ago. Basic loss per share from continuing operations was USD 1.29 compared to basic earnings per share from continuing operations of USD 2.74 a year ago. Diluted loss per share from continuing operations was USD 1.29 compared to diluted earnings per share from continuing operations of USD 2.73 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

0C8 Income Statement

Gross margin TTM 24.79%
Operating margin TTM 1.71%
Net Profit margin TTM -5.43%
Return on Investment TTM 0.65%
 Total Revenue  Net Income
Period Ending: Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022
Total Revenue 1068 1037 1149 1022
Gross Profit 235 180 387 258
Operating Income -100 -11 162 56
Net Income -86 -227 81 0

0C8 Balance Sheet

Quick Ratio MRQ 0.83
Current Ratio MRQ 1.78
LT Debt to Equity MRQ 93.05%
Total Debt to Equity MRQ 104.62%
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022
Total Assets 10782 10830 11147 10205
Total Liabilities 6147 6127 6235 5505
Total Equity 4635 4703 4912 4700

0C8 Cash Flow Statement

Cash Flow/Share TTM 1.45
Revenue/Share TTM 23.72
Operating Cash Flow  13.47%
 Cash  Net Change in Cash
Period Ending: Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 203 -64 214 -92
Cash From Investing Activities -128 -110 -608 -116
Cash From Financing Activities -51 -25 523 74
Net Change in Cash 28 -190 161 -168
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CTLT Comments

Write your thoughts about Catalent Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
May 26, 2023 11:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
an undervalue is not what you want... needs are fairvalue
Michela Harnish
Michela Harnish May 19, 2023 4:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hello
Ryan Wright
Ryan Wright May 17, 2023 5:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
New 52-week low yesterday. Q3 '23 ER delayed 3 times already. Hmmm, what else could possibly go wrong on Fri.?
Luka Tsirekidze
Luka Tsirekidze May 12, 2023 3:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
target 45$
Antoine Neaime
Antoine Neaime Nov 02, 2022 3:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will close 49.5 usd
Grégory Vervoort
Grégory Vervoort Aug 12, 2022 3:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mega deal to come with Mithra ?
Hyungjin Lee
Hyungjin Lee Dec 08, 2020 6:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
moderna, regeneron, j&j
Jim Keener
Jim Keener Apr 16, 2020 6:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
solid growth company
Steven Culpepper
Steven Culpepper Jun 21, 2016 4:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Market close 21 Jun appears like frying pan...
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email